Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland

Kevin Van Cott, Barry Williams, William H Velander, Frank Gwazdauskas, Tim Lee, Henryk Lubon, William N. Drohan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Recombinant human protein C (rhPC) secreted in the milk of transgenic pigs was studied. Transgenes having different regulatory elements of the murine milk protein, whey acidic protein, were used with cDNA and genomic human protein C (hPC) DNA sequences to obtain lower and higher expressing animals. The cDNA pigs had a range of expression of about 0.1-0.5 g/l milk. Two different genomic hPC pig lines have expressed 0.3 and 1-2 g/l, respectively. The rhPC was first purified at yields greater than 60 per cent using a monoclonal antibody (mAb) to the activation site on the heavy chain of hPC. Subsequent immunopurification with a calcium-dependent mAb directed to the γ-carboxyglutamic acid domain of the light chain of hPC was used to fractionate a population having a higher specific anticoagulant activity in vitro. The higher percentages of Ca2+-dependent conformers isolated from the total rhPC by immunopurification correlated well with higher specific activity and lower expression. A rate limitation in γ-carboxylation of rhPC was clearly identified for the higher expressing animals. Thus, transgenic animals with high expression levels of complex recombinant proteins produced a lower percentage of biologically active protein.

Original languageEnglish (US)
Pages (from-to)407-414
Number of pages8
JournalJournal of Molecular Recognition
Volume9
Issue number5-6
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Human Mammary Glands
Protein C
Recombinant Proteins
Purification
Swine
Proteins
Animals
Monoclonal antibodies
Milk
Complementary DNA
Monoclonal Antibodies
Carboxylation
Genetically Modified Animals
Milk Proteins
DNA sequences
Recombinant proteins
Transgenes
Anticoagulants
Chemical activation
Calcium

Keywords

  • Affinity chromatography
  • Mammary gland
  • Porcine
  • Protein C
  • Transgenic

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology

Cite this

Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland. / Van Cott, Kevin; Williams, Barry; Velander, William H; Gwazdauskas, Frank; Lee, Tim; Lubon, Henryk; Drohan, William N.

In: Journal of Molecular Recognition, Vol. 9, No. 5-6, 01.01.1996, p. 407-414.

Research output: Contribution to journalArticle

Van Cott, Kevin ; Williams, Barry ; Velander, William H ; Gwazdauskas, Frank ; Lee, Tim ; Lubon, Henryk ; Drohan, William N. / Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland. In: Journal of Molecular Recognition. 1996 ; Vol. 9, No. 5-6. pp. 407-414.
@article{804a3f668165491f84307cb425c2770a,
title = "Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland",
abstract = "Recombinant human protein C (rhPC) secreted in the milk of transgenic pigs was studied. Transgenes having different regulatory elements of the murine milk protein, whey acidic protein, were used with cDNA and genomic human protein C (hPC) DNA sequences to obtain lower and higher expressing animals. The cDNA pigs had a range of expression of about 0.1-0.5 g/l milk. Two different genomic hPC pig lines have expressed 0.3 and 1-2 g/l, respectively. The rhPC was first purified at yields greater than 60 per cent using a monoclonal antibody (mAb) to the activation site on the heavy chain of hPC. Subsequent immunopurification with a calcium-dependent mAb directed to the γ-carboxyglutamic acid domain of the light chain of hPC was used to fractionate a population having a higher specific anticoagulant activity in vitro. The higher percentages of Ca2+-dependent conformers isolated from the total rhPC by immunopurification correlated well with higher specific activity and lower expression. A rate limitation in γ-carboxylation of rhPC was clearly identified for the higher expressing animals. Thus, transgenic animals with high expression levels of complex recombinant proteins produced a lower percentage of biologically active protein.",
keywords = "Affinity chromatography, Mammary gland, Porcine, Protein C, Transgenic",
author = "{Van Cott}, Kevin and Barry Williams and Velander, {William H} and Frank Gwazdauskas and Tim Lee and Henryk Lubon and Drohan, {William N.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1002/(SICI)1099-1352(199634/12)9:5/6<407::AID-JMR277>3.0.CO;2-X",
language = "English (US)",
volume = "9",
pages = "407--414",
journal = "Journal of Molecular Recognition",
issn = "0952-3499",
publisher = "John Wiley and Sons Ltd",
number = "5-6",

}

TY - JOUR

T1 - Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland

AU - Van Cott, Kevin

AU - Williams, Barry

AU - Velander, William H

AU - Gwazdauskas, Frank

AU - Lee, Tim

AU - Lubon, Henryk

AU - Drohan, William N.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Recombinant human protein C (rhPC) secreted in the milk of transgenic pigs was studied. Transgenes having different regulatory elements of the murine milk protein, whey acidic protein, were used with cDNA and genomic human protein C (hPC) DNA sequences to obtain lower and higher expressing animals. The cDNA pigs had a range of expression of about 0.1-0.5 g/l milk. Two different genomic hPC pig lines have expressed 0.3 and 1-2 g/l, respectively. The rhPC was first purified at yields greater than 60 per cent using a monoclonal antibody (mAb) to the activation site on the heavy chain of hPC. Subsequent immunopurification with a calcium-dependent mAb directed to the γ-carboxyglutamic acid domain of the light chain of hPC was used to fractionate a population having a higher specific anticoagulant activity in vitro. The higher percentages of Ca2+-dependent conformers isolated from the total rhPC by immunopurification correlated well with higher specific activity and lower expression. A rate limitation in γ-carboxylation of rhPC was clearly identified for the higher expressing animals. Thus, transgenic animals with high expression levels of complex recombinant proteins produced a lower percentage of biologically active protein.

AB - Recombinant human protein C (rhPC) secreted in the milk of transgenic pigs was studied. Transgenes having different regulatory elements of the murine milk protein, whey acidic protein, were used with cDNA and genomic human protein C (hPC) DNA sequences to obtain lower and higher expressing animals. The cDNA pigs had a range of expression of about 0.1-0.5 g/l milk. Two different genomic hPC pig lines have expressed 0.3 and 1-2 g/l, respectively. The rhPC was first purified at yields greater than 60 per cent using a monoclonal antibody (mAb) to the activation site on the heavy chain of hPC. Subsequent immunopurification with a calcium-dependent mAb directed to the γ-carboxyglutamic acid domain of the light chain of hPC was used to fractionate a population having a higher specific anticoagulant activity in vitro. The higher percentages of Ca2+-dependent conformers isolated from the total rhPC by immunopurification correlated well with higher specific activity and lower expression. A rate limitation in γ-carboxylation of rhPC was clearly identified for the higher expressing animals. Thus, transgenic animals with high expression levels of complex recombinant proteins produced a lower percentage of biologically active protein.

KW - Affinity chromatography

KW - Mammary gland

KW - Porcine

KW - Protein C

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=0030225322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030225322&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-1352(199634/12)9:5/6<407::AID-JMR277>3.0.CO;2-X

DO - 10.1002/(SICI)1099-1352(199634/12)9:5/6<407::AID-JMR277>3.0.CO;2-X

M3 - Article

VL - 9

SP - 407

EP - 414

JO - Journal of Molecular Recognition

JF - Journal of Molecular Recognition

SN - 0952-3499

IS - 5-6

ER -